
OACC P/E Ratio
P/E Ratio as of Oct 13, 2025: 53.46
Average53.38
Median53.43
Minimum53.26
Maximum53.46
53.46
The P/E ratio for OACC is 53.46 as of Oct 13, 2025. This represents a increase of 1,104.05% compared to its 12-month average P/E ratio of 4.44. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Oaktree Acquisition Corp III Life Sciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Oaktree Acquisition Corp III Life Sciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Oaktree Acquisition Corp III Life Sciences to industry peers.
Oaktree Acquisition Corp III Life Sciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Oaktree Acquisition Corp III Life Sciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Oaktree Acquisition Corp III Life Sciences to industry peers.
OACC P/E Ratio Insights
See Oaktree Acquisition Corp III Life Sciences’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in OACC
Order type
Buy in
Order amount
Est. shares
0 shares
OACC P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Oct 6, 2025 | $10.53 | 53.26 |
OACC End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | 53.46 | — |
FAQs About Oaktree Acquisition Corp III Life Sciences (OACC) P/E ratio
The latest P/E ratio of OACC is 53.46, as of Oct 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Oaktree Acquisition Corp III Life Sciences’s last 12-month average P/E ratio is 4.44, compared to its current P/E ratio of 53.46. This reflects a increase of 1,104.05%.
Oaktree Acquisition Corp III Life Sciences’s current P/E ratio of 53.46 is higher than its last 12-month average P/E of 4.44. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Oaktree Acquisition Corp III Life Sciences’s average P/E ratio over the last 3 years is 1.48. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Oaktree Acquisition Corp III Life Sciences’s average P/E ratio over the last 5 years is 0.89. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.